Biocure 2 mg Injection
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Biocure 2 mg Injection

Biocure 2 mg Injection

Biocure 2 mg Injection contains bortezomib and is an anticancer medicine used to treat multiple myeloma and mantle cell lymphoma. It belongs to a group of medicines called proteasome inhibitors that help slow or stop the growth of cancer cells. The injection is administered by a qualified healthcare professional under medical supervision.

BUY NOW

Category

Bortezomib works by inhibiting the proteasome system inside cells, which can lead to the death of cancer cells. Biocure 2 mg Injection may be used alone or in combination with other anticancer medicines according to the prescribed treatment regimen. It is supplied as a powder for injection and requires preparation before administration by trained medical personnel. Blood cell counts and other clinical parameters may be monitored regularly during treatment to help manage potential adverse effects.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 2 mg
Dosage Form Powder for Injection
Therapeutic Class Anti-neoplastic
Pack Size 1 vial
Manufacturer Emcure Pharmaceuticals Ltd

Product Also Known As

Biocure 2 mg, Biocure 2 mg Injection, Biocure 2 mg Injection 1 Vial, Bortezomib 2 mg Injection, Bortezomib Injection, Proteasome Inhibitor Injection, Multiple Myeloma Injection